Variants of the 3' Region of the CagA Gene in Helicobacter Pylori Isolates from Patients with Different H. Pylori-associated Diseases

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1998 Jul 17

PMID 9666002

Citations 130

Authors

Y Yamaoka

T Kodama

K Kashima

D Y Graham

A R Sepulveda

Affiliations

Soon will be listed here.

Abstract

The CagA protein of Helicobacter pylori is an immunogenic antigen of variable size and unknown function that has been associated with increased virulence as well as two mutually exclusive diseases, duodenal ulcer and gastric carcinoma. The 3' region of the cagA gene contains repeated sequences. To determine whether there are structural changes in the 3' region of cagA that predict outcome of H. pylori infection, we examined 155 cagA gene-positive H. pylori isolates from Japanese patients including 50 patients with simple gastritis, 40 with gastric ulcer, 35 with duodenal ulcer, and 30 with gastric cancer. The 3' region of the cagA gene was amplified by PCR followed by sequencing. CagA proteins were detected by immunoblotting using a polyclonal antibody against recombinant CagA. One hundred forty-five strains yielded PCR products of 642 to 651 bp; 10 strains had products of 756 to 813 bp. The sequence of the 3' region of the cagA gene in Japan differs markedly from the primary sequence of cagA genes from Western isolates. Sequence analysis of the PCR products showed four types of primary gene structure (designated types A, B, C, and D) depending on the type and number of repeats. Six of the seven type C strains were found in patients with gastric cancer (P < 0.01 in comparison to noncancer patients). Comparison of type A and type C strains from patients with gastric cancer showed that type C was associated with higher levels of CagA antibody and more severe degrees of atrophy. Differences in cagA genotype may be useful for molecular epidemiology and may provide a marker for differences in virulence among cagA-positive H. pylori strains.

Citing Articles

Pivotal role of virulence genes in pathogenicity and vaccine development.

Elbehiry A, Marzouk E, Abalkhail A, Sindi W, Alzahrani Y, Alhifani S Front Med (Lausanne). 2025; 11():1523991.

PMID: 39850097 PMC: 11756510. DOI: 10.3389/fmed.2024.1523991.

Long-term assessment of Helicobacter pylori cagA EPIYA motif changes and pathology outcomes in gastric biopsies of dyspeptic patients: 10-year follow-up.

Ghadersoltani P, Shoraka S, Sadjadi A, Saniee P BMC Gastroenterol. 2024; 24(1):466.

PMID: 39702056 PMC: 11660904. DOI: 10.1186/s12876-024-03516-0.

Helicobacter pylori Cytotoxin-Associated Gene A (cagA) and Vacuolating Cytotoxin Gene A (vacA) Genotypes in Gastrointestinal Patients From Central Thailand.

Sukthaworn S, Moungthard H, Sirisai C, Anuponganan W, Peerathippayamongkol C, Mus-U-Dee M Cureus. 2024; 16(7):e64164.

PMID: 39119398 PMC: 11309081. DOI: 10.7759/cureus.64164.

and Its Role in Gastric Cancer.

Reyes V Microorganisms. 2023; 11(5).

PMID: 37317287 PMC: 10220541. DOI: 10.3390/microorganisms11051312.

The Association Between Oral Helicobacter pylori and Gastric Complications: A Comprehensive Review.

Alkhaldi N, Alghamdi W, Alharbi M, Almutairi A, Alghamdi F Cureus. 2022; 14(5):e24703.

PMID: 35663643 PMC: 9162906. DOI: 10.7759/cureus.24703.

References

Sonnenberg A . The US temporal and geographic variations of diseases related to Helicobacter pylori. Am J Public Health. 1993; 83(7):1006-10. PMC: 1694789. DOI: 10.2105/ajph.83.7.1006. View

Parsonnet J, Friedman G, ORENTREICH N, Vogelman H . Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997; 40(3):297-301. PMC: 1027076. DOI: 10.1136/gut.40.3.297. View

Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N . Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut. 1998; 42(3):338-43. PMC: 1727030. DOI: 10.1136/gut.42.3.338. View

Tummuru M, Cover T, Blaser M . Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993; 61(5):1799-809. PMC: 280768. DOI: 10.1128/iai.61.5.1799-1809.1993. View

Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J . Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997; 41(4):442-51. PMC: 1891528. DOI: 10.1136/gut.41.4.442. View

Miehlke S, Kibler K, Kim J, Figura N, Small S, Graham D . Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol. 1996; 91(7):1322-5. View

Warren J, Marshall B . Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983; 1(8336):1273-5. View

Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G . Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993; 90(12):5791-5. PMC: 46808. DOI: 10.1073/pnas.90.12.5791. View

Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M . High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci. 1997; 42(9):1841-7. DOI: 10.1023/a:1018846723379. View

10.

Xiang Z, Censini S, Bayeli P, Telford J, Figura N, Rappuoli R . Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun. 1995; 63(1):94-8. PMC: 172962. DOI: 10.1128/iai.63.1.94-98.1995. View

11.

Sharma S, Tummuru M, Miller G, Blaser M . Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun. 1995; 63(5):1681-87. PMC: 173210. DOI: 10.1128/iai.63.5.1681-1687.1995. View

12.

Graham D, Lew G, KLEIN P, Evans D, Evans Jr D, Saeed Z . Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992; 116(9):705-8. DOI: 10.7326/0003-4819-116-9-705. View

13.

Whittam T, Wolfe M, Wachsmuth I, ORSKOV F, ORSKOV I, Wilson R . Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect Immun. 1993; 61(5):1619-29. PMC: 280743. DOI: 10.1128/iai.61.5.1619-1629.1993. View

14.

Pan Z, van der Hulst R, Feller M, Xiao S, Tytgat G, Dankert J . Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol. 1997; 35(6):1344-7. PMC: 229746. DOI: 10.1128/jcm.35.6.1344-1347.1997. View

15.

Graham D . Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 1997; 113(6):1983-91. DOI: 10.1016/s0016-5085(97)70019-2. View

16.

Blaser M, Perez-Perez G, Kleanthous H, Cover T, Peek R, Chyou P . Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995; 55(10):2111-5. View

17.

. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet. 1993; 341(8857):1359-62. View

18.

Censini S, Lange C, Xiang Z, Crabtree J, Ghiara P, Borodovsky M . cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996; 93(25):14648-53. PMC: 26189. DOI: 10.1073/pnas.93.25.14648. View

19.

Tummuru M, Cover T, Blaser M . Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun. 1994; 62(6):2609-13. PMC: 186552. DOI: 10.1128/iai.62.6.2609-2613.1994. View

20.

Xiang Z, Bugnoli M, Ponzetto A, Morgando A, Figura N, Covacci A . Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis. 1993; 12(10):739-45. DOI: 10.1007/BF02098460. View